DSI - DS InPharmatics
Meranda Parascandola has a diverse work experience in the pharmaceutical industry. Meranda began their career as a Regulatory Affairs Specialist at eVenus Pharmaceutical Laboratories, Inc. from November 2009 to May 2015. In this role, they managed FDA SPL filings, orchestrated regulatory submissions, and ensured timely responses to the agency.
Meranda then joined ForDoz Pharma in March 2016 as an Office Manager, where they successfully managed office operations and oversaw the relocation of the company to a new office and lab location. Meranda also created office processes and procedures manuals and managed company files and databases.
Following their time at ForDoz Pharma, Meranda worked at Emprise Pharma LLC as a Consulting Regulatory Affairs Manager from June 2015 to September 2019. In this role, they provided regulatory consulting services and led the preparation of regulatory assessments and applications. Meranda developed electronic common technical document (eCTD) templates and managed the eCTD filings.
Most recently, Meranda joined DSI - Design Space InPharmatics LLC in June 2017. Meranda initially served as the Director of Marketing & Business Development, assisting the owner with sales and marketing activities. Meranda reviewed and updated the CRM to a B2B platform. Meranda then transitioned into the role of Head of Business Development & Marketing, where they led a team and directed all business development and marketing activities, including budget preparation and goal monitoring.
Throughout their career, Meranda has demonstrated strong leadership skills, regulatory expertise, and the ability to effectively manage office operations.
Meranda Parascandola pursued their education at the City University of New York-College of Staten Island from 2007 to 2009. During this period, they successfully completed their associate's degree in Business Administration and Management, General. In addition to their formal education, Meranda has also obtained a certification in Adobe Illustrator, although the details regarding the institution, month, and year of obtaining the certification are not provided.
This person is not in any teams
This person is not in any offices
DSI - DS InPharmatics
DS InPharmatics (DSI) offers one-stop, full-service CMC consulting resources to emerging pharmaceutical and biopharmaceutical companies. The exceptional value DS InPharmatics offers begins with our dedicated, multidisciplinary teams of manufacturing, quality, and regulatory affairs specialists. Our CMC consultants combine in-depth technical knowledge of product development with risk-based submission content and regulatory strategies for all phases of the review and approval process. This breadth of pharmaceutical development expertise provides you with a single, integrated source for efficient problem-solving strategies and scientific expertise. Whether your needs are comprehensive or tightly focused on a specific project, our experienced CMC consultants will help keep your drug development program on track. Not just advice. DSI provides you with hands-on, flexible resources and expanded operational capability, to implement a compliant drug development strategy and timelines. In April 2021 we were thrilled to announce that DSI has just become part of ProductLife Group. Our merger with PLG will harness our combined strengths, offering our clients on both sides of the Atlantic support with their developed drugs approvals and post-approvals compliance, plus advisory services on the best market strategies to deliver a rapid ROI on their development. Together we will offer our clients increased pharmacovigilance capabilities - including a QPPV; pharmacovigilance consulting; and a fully validated safety database – as well as complementary toxicology-related services; RIM/electronic document management services; and support for medical device regulatory requirements. We see enormous potential in this new chapter for DSI and for you, our clients. As a PLG company, we have the opportunity to become part of a global force in life sciences regulatory and compliance solutions and services, and we’re incredibly excited to add our momentum to that effort.